News
Apixaban Tied to Lower Risk for Recurrent VTE in Dialysis Population
Apixaban is a direct oral anticoagulant that relies less on kidney excretion.
Your search for Warfarin returned 36 results
Clinical Charts
Thromboembolic Disorder Assessment: DVT/PE
Risk factors, prevention strategies, signs & symptoms, and general treatment options for deep vein thrombosis (DVT) and pulmonary embolism (PE).
News
Potential Links ID’d for Marijuana Use, Cardiovascular Risks
Key classes of cardiovascular medications are affected by marijuana, including statins, β-blockers.
News
GI Bleed Hospitalization Risk Linked to Oral Anticoagulant Choice, PPI Cotherapy
To compare the incidence of hospitalization for upper GI tract bleeding, researchers used US Medicare beneficiary files to identify a cohort of patients that were ≥30 years old who initiated oral anticoagulation therapy with apixaban, dabigatran, rivaroxaban, or warfarin, with or without PPI cotherapy.
News
Impact of Oral Anticoagulants on Renal Outcomes Compared
Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes
News
Anticoagulation During Pregnancy Linked to Distinct Maternal, Fetal Risks
VKA, LMWH tied to lowest risk of adverse maternal, fetal outcomes, respectively
News
Benefits of Warfarin After Dementia Diagnosis Explored
For veterans receiving warfarin for nonvalvular atrial fibrillation, continuing warfarin after a diagnosis of dementia is associated with a protective effect in prevention of stroke and mortality, according to a study published online December 30 in the Journal of the American Geriatrics Society.
Features
Six Popular Supplements Used for Diabetes Management
Although use of dietary supplements is not always recommended, it is best for clinicians to be knowledgeable about the safety and efficacy data surrounding them in order to assist patients who choose to use them.
News
Warfarin Discontinuation Linked to Increased Risk of Death, Adverse Events in Very Elderly
Physician-perceived frailty and low life expectancy are the main reasons for warfarin discontinuation in elderly patients
News
Drug Interaction Possible When HCV Regimens Added to Warfarin
A retrospective cohort study in the Annals of Pharmacotherapy found a clinically significant decrease in warfarin dose-response with concurrent hepatitis C treatments, especially with ombitasvir/paritaprevir/ritonavir and dasabuvir (OBV-PTV/r-DSV).
